Trial Profile
Phase II randomized study of two different schedules of intravenous clofarabine in myelodysplastic syndrome (MDS).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2013
Price :
$35
*
At a glance
- Drugs Clofarabine (Primary)
- Indications Chronic myelomonocytic leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 08 Nov 2013
- 05 Dec 2011 Actual end date (Nov 2011 ) added as reported by ClinicalTrials.gov.
- 05 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.